Skip to main content
Midas Edge

Kiniksa Pharmaceuticals Ltd

For the period ended Mar 31, 2024. Filed Apr 25, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed Apr 25, 2024

KNSA$98.76+5.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

​​​Incorporated by Reference
ExhibitNumberExhibit DescriptionFormFile No.ExhibitFilingDateFiled/FurnishedHerewith
​​​​​​​​​​​​​
10.1#+​Consulting Agreement by and between Kiniksa Pharmaceuticals, Ltd. and Dr. Richard Levy​​​​​​​​​*
​​​​​​​​​​​​​
10.2#†​Form of 2024 Performance Share Unit Grant Notice and 2024 Performance Share Unit Award Agreement​​​​​​​​​*
​​​​​​​​​​​​​
31.1​Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer​​​​​​​​​*
​​​​​​​​​​​​​
31.2​Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer​​​​​​​​​*
​​​​​​​​​​​​​
32.1​Section 1350 Certification of Chief Executive Officer​​​​​​​​​**
​​​​​​​​​​​​​
32.2​Section 1350 Certification of Chief Financial Officer​​​​​​​​​**
​​​​​​​​​​​​​
101.INS​XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document​​​​​​​​​***
​​​​​​​​​​​​​
101.SCH​Inline XBRL Taxonomy Extension Schema Document​​​​​​​​​***
​​​​​​​​​​​​​
101.CAL​Inline XBRL Taxonomy Extension Calculation Linkbase Document​​​​​​​​​***
​​​​​​​​​​​​​
101.DEF​Inline XBRL Extension Definition Linkbase Document​​​​​​​​​***
​​​​​​​​​​​​​
101.LAB​Inline XBRL Taxonomy Label Linkbase Document​​​​​​​​​***
​​​​​​​​​​​​​
101.PRE​Inline XBRL Taxonomy Extension Presentation Linkbase Document​​​​​​​​​***
​​​​​​​​​​​​​
104​Cover page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document​​​​​​​​​***
#Indicates management contract or compensatory plan
†Portions of the exhibit have been redacted in compliance with Regulation S-K Item 601(b)(10)(iv)
+Portions of the exhibit have been redacted in compliance with Regulation S-K Item 601(a)(6)
*Filed herewith
**Furnished herewith
***Submitted electronically herewith
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.